Pharmacy Fall Conference - 2014

Herpes Zoster (Shingles) and Zostavax®

Activity Details
  • Credit Type: CPE
  • Credit Amount: 1.00
  • Cost: $5.00
  • Release: Feb 9, 2015
  • Expires: Oct 23, 2017
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)


Stacey Emmons Stacey Emmons, PharmD
Rite Aid
Field Clinical Services Manager
Region 50003
Lexington, KY

Needs Statement

Suboptimal screening and recommendation of herpes zoster vaccination has led to below goal vaccination rates in patients indicated for the vaccine. Healthcare providers as a whole must work together to increase the recommendations and administrations of vaccines. Pharmacy must use its accessibility to aid in increasing vaccination rates, particularly herpes zoster vaccination.

Target Audience



Upon Completion of this activity Pharmacist will be able to:

1. Review epidemiology and pathophysiology of shingles
2. Discuss immunization indications for Zostavax®


ACPEThe University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0022-0000-15-014-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Faculty Disclosure

Stacey Emmons, PharmD (Speaker) has no relevant financial relationships with commercial interests.

Stacey Emmons does not intend to discuss the off-label use of a product.

No planners have any relevant financial relationships to disclose.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.